Literature DB >> 3872432

Radiographic, clinical, and histopathologic evaluation with surgical treatment of Forestier's disease.

J G Barsamian, L W Cobb, A M Bremer, R B Scheffer, H M Northup.   

Abstract

Diffuse idiopathic skeletal hyperostosis (Forestier's disease) is a common disorder found in the spinal region, but the notable finding in this case presentation is the associated dysphagia and dysphonia that occurred with it. Asymptomatic hypertrophic spurs of the anterior surface of the cervical vertebrae may occur in 20% to 30% of the population. Rarely, dysphagia and/or dysphonia may be caused by these cervical osteophytes pressing against the esophagus, trachea, or pharyngeal tissues. A recent case of spondylitic dysphagia exhibited striking radiographic and computerized tomographic (CT) findings. In this case, the anterior cervical exostosis was resected through the anterior cervical approach with excellent relief of dysphagia.

Entities:  

Mesh:

Year:  1985        PMID: 3872432     DOI: 10.1016/0030-4220(85)90004-0

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  4 in total

1.  Cervical involvement of diffuse idiopathic skeletal hyperostosis with dysphagia and rhinolalia.

Authors:  S Kristensen; K M Sander; P R Pedersen
Journal:  Arch Otorhinolaryngol       Date:  1988

2.  Updated management strategy for patients with cervical osteophytic dysphagia.

Authors:  A B Valadka; W S Kubal; M M Smith
Journal:  Dysphagia       Date:  1995       Impact factor: 3.438

3.  Long term follow-up of diffuse idiopathic skeletal hyperostosis in the cervical spine. Analysis of progression of ossification.

Authors:  K Suzuki; Y Ishida; K Ohmori
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

4.  Dystrophic calcification and heterotopic ossification in fibrocartilaginous tissues of the spine in diffuse idiopathic skeletal hyperostosis (DISH).

Authors:  Dale E Fournier; Patti K Kiser; Ryan J Beach; S Jeffrey Dixon; Cheryle A Séguin
Journal:  Bone Res       Date:  2020-04-02       Impact factor: 13.567

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.